• Corpus ID: 231741112

Detecting Pulmonary Coccidioidomycosis (Valley fever) with Deep Convolutional Neural Networks

  title={Detecting Pulmonary Coccidioidomycosis (Valley fever) with Deep Convolutional Neural Networks},
  author={Jordan Ott and David S. Bruyette and Cody L. Arbuckle and Dylan Balsz and Silke Hecht and Lisa F. Shubitz and Pierre Baldi},
Coccidioidomycosis is the most common systemic mycosis in dogs in the southwestern United States. With warming climates, affected areas and number of cases are expected to increase in the coming years, escalating also the chances of transmission to humans. As a result, developing methods for automating the detection of the disease is important, as this will help doctors and veterinarians more easily identify and diagnose positive cases. We apply machine learning models to provide accurate and… 

Figures and Tables from this paper



Expansion of Coccidioidomycosis Endemic Regions in the United States in Response to Climate Change

A predictive model of Valley fever endemicity may provide guidance to public health officials to establish disease surveillance programs and design mitigation efforts to limit the impacts of this disease.

Clinicopathologic and Histopathologic Renal Abnormalities in Dogs with Coccidioidomycosis

Coccidioidomycosis should be considered as a possible contributor to glomerular disease in dogs and whether similar lesions occur in other mammalian hosts, including humans, warrants further investigation.

Comparative Aspects of Coccidioidomycosis in Animals and Humans

  • L. Shubitz
  • Biology, Medicine
    Annals of the New York Academy of Sciences
  • 2007
Dogs seem to have a susceptibility similar to that of humans, with subclinical infections, mild‐to‐severe primary pulmonary disease, and disseminated disease, whereas central nervous system disease in humans is typically meningitis, brain disease in dogs and cats takes the form of granulomatous parenchymal masses.

Primary Cutaneous Coccidioidomycosis in an Italian Nun Working in South America and Review of Published Literature

An unusual case of PCC characterized by a persistent solitary lesion diagnosed in Italy in an immunocompetent Italian nun living in Argentina is described and the isolate was identified by sequence analysis as C. posadasii.

Automated pulmonary nodule detection using 3D deep convolutional neural networks

This paper introduces a novel DCNN approach, consisting of two stages, that is fully three-dimensional end-to-end and utilizes the state-of-the-art in object detection and ranked first in Season One of Alibaba's 2017 TianChi AI Competition for Healthcare.

Detecting Cardiovascular Disease from Mammograms With Deep Learning

The results suggest that deep learning can be used effectively to develop an automated system for BAC detection inmammograms to help identify and assess patients with cardiovascular risks.

Dermatologist-level classification of skin cancer with deep neural networks

This work demonstrates an artificial intelligence capable of classifying skin cancer with a level of competence comparable to dermatologists, trained end-to-end from images directly, using only pixels and disease labels as inputs.

Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas

For The Cancer Imaging Archives dataset, machine-learning approaches allow classification of individual genetic mutations of both low- and high-grade gliomas and relevant MR imaging features acquired from an added dimensionality-reduction technique demonstrate that neural networks are capable of learning key imaging components without prior feature selection or human directed training.

Deep Learning Localizes and Identifies Polyps in Real Time With 96% Accuracy in Screening Colonoscopy.

The ability of computer-assisted image analysis using convolutional neural networks (CNNs; a deep learning model for image analysis) to improve polyp detection, a surrogate of ADR, is tested and could increase the ADR and decrease interval colorectal cancers but requires validation in large multicenter trials.